A detailed history of M&T Bank Corp transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 2,278 shares of BIO stock, worth $630,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,278
Previous 2,370 3.88%
Holding current value
$630,869
Previous $765,000 2.88%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$304.11 - $351.99 $27,978 - $32,383
-92 Reduced 3.88%
2,278 $787,000
Q4 2023

Feb 06, 2024

SELL
$269.37 - $365.04 $33,401 - $45,264
-124 Reduced 4.97%
2,370 $765,000
Q3 2023

Nov 02, 2023

SELL
$350.25 - $422.63 $132,394 - $159,754
-378 Reduced 13.16%
2,494 $893,000
Q2 2023

Aug 09, 2023

SELL
$359.49 - $486.4 $56,439 - $76,364
-157 Reduced 5.18%
2,872 $1.09 Million
Q1 2023

May 11, 2023

BUY
$418.69 - $503.0 $98,810 - $118,708
236 Added 8.45%
3,029 $1.45 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $524,751 - $680,366
1,492 Added 51.11%
4,411 $1.86 Million
Q4 2022

Feb 13, 2023

SELL
$351.71 - $456.01 $569,066 - $737,824
-1,618 Reduced 36.68%
2,793 $1.17 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $226,099 - $308,666
-548 Reduced 15.81%
2,919 $1.22 Million
Q2 2022

Aug 05, 2022

BUY
$463.67 - $597.16 $850,834 - $1.1 Million
1,835 Added 112.44%
3,467 $836,000
Q1 2022

May 09, 2022

BUY
$524.57 - $735.42 $41,965 - $58,833
80 Added 5.15%
1,632 $919,000
Q4 2021

Feb 07, 2022

BUY
$708.84 - $794.68 $46,074 - $51,654
65 Added 4.37%
1,552 $1.17 Million
Q3 2021

Oct 28, 2021

BUY
$657.71 - $825.77 $5,261 - $6,606
8 Added 0.54%
1,487 $1.11 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $576 - $649
1 Added 0.07%
1,479 $953,000
Q1 2021

May 06, 2021

SELL
$547.01 - $662.35 $210,051 - $254,342
-384 Reduced 20.62%
1,478 $844,000
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $462,676 - $582,965
906 Added 94.77%
1,862 $1.09 Million
Q3 2020

Nov 06, 2020

BUY
$454.43 - $535.6 $40,444 - $47,668
89 Added 10.27%
956 $493,000
Q2 2020

Jul 29, 2020

SELL
$334.87 - $493.06 $130,599 - $192,293
-390 Reduced 31.03%
867 $391,000
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $8,320 - $10,635
26 Added 2.11%
1,257 $441,000
Q4 2019

Feb 07, 2020

SELL
$319.73 - $374.2 $7,673 - $8,980
-24 Reduced 1.91%
1,231 $455,000
Q3 2019

Nov 12, 2019

SELL
$304.55 - $345.24 $52,382 - $59,381
-172 Reduced 12.05%
1,255 $419,000
Q2 2019

Aug 12, 2019

SELL
$286.93 - $312.59 $105,590 - $115,033
-368 Reduced 20.5%
1,427 $447,000
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $8,523 - $12,061
38 Added 2.16%
1,795 $549,000
Q4 2018

Feb 01, 2019

SELL
$220.1 - $309.0 $271,383 - $380,997
-1,233 Reduced 41.24%
1,757 $408,000
Q3 2018

Nov 09, 2018

BUY
$289.28 - $326.15 $6,942 - $7,827
24 Added 0.81%
2,990 $937,000
Q2 2018

Aug 10, 2018

BUY
$244.1 - $303.88 $292,187 - $363,744
1,197 Added 67.67%
2,966 $855,000
Q1 2018

May 04, 2018

SELL
$233.97 - $274.11 $99,437 - $116,496
-425 Reduced 19.37%
1,769 $443,000
Q4 2017

Feb 06, 2018

SELL
$216.94 - $271.3 $55,536 - $69,452
-256 Reduced 10.45%
2,194 $522,000
Q3 2017

Nov 13, 2017

BUY
$212.27 - $242.28 $26,746 - $30,527
126 Added 5.42%
2,450 $544,000
Q2 2017

Aug 11, 2017

BUY
N/A
2,324
2,324 $525,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.82B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.